|
|
|
|
|
|
|
|
02010
|
RUINIAN INTERNATIONAL LIMITED
|
|
|
Profile
|
|
|
Chairman
|
|
Mr. WANG Fucai
|
|
|
Directors
|
|
WANG Fucai (Chairman & CEO & Executive Director)
YU Yan (Executive Director)
LI Lin (Executive Director)
YI Lin (Executive Director)
ZHANG Yan (Executive Director)
AU-YEUNG Kam Ling Celeste (Executive Director)
IP Tak Chuen Edmond (Non-Executive Director)
WONG Lung Tak Patrick (Independent Non-Executive Director)
FONG Chi Wah (Independent Non-Executive Director)
Bernard Ban-yew YAW (Independent Non-Executive Director)
|
|
|
Secretary
|
|
Mr. POON Yick Pang, Philip
|
|
|
Address
|
|
Unit A, 10th Floor, China Overseas Building, No.139 Hennessy Road and No.138 Lockhart Road, Wan Chai, Hong Kong
|
|
|
Tel
|
|
|
|
|
Fax
|
|
|
|
|
URL
|
|
http://www.ruinian.com.cn
|
|
|
Business nature
|
|
The Group is engaged in the amino acid-based
nutritional supplements in the rapidly growing Chinese market.
[IPO Information]
|
|
|
Prospects
|
|
The Group will continue to consolidate its leading position in amino acids health supplement market in the PRC. The Group targets to expand its distribution outlets to over 50,000 by the end of 2010. The Group will replicate its high penetration distribution model in the Yangzi River Delta in other provinces in the PRC. Priority will be given to Southern and Central provinces of strong consumption power, with focus on cities like Guangzhou, Shenzhen, Chengdu, and Wuhan. 8 regional sales conferences for distributors will be held this year to update distributors with the Group’s latest product information, market trend, and most importantly, the Group’s teaming strategies in expanding the amino acids heath supplement market in the PRC. At the consumer level, 300 promotional events in key supermarkets, hypermarkets and chain stores will be held throughout the year to educate consumers of the benefits of amino acid products and how the Group’s products would serve their needs. The Group would also sponsor major sports and social events to improve the publicity of Ruinian brand.
|
|
|
Major shareholder
|
|
Mr. WANG Fucai
(38.07%)
CK Life Sciences
(8.92%)
Raffles Partners
(5.47%)
|
|
|
|
Stock Information Provided by Infocast Limited
[
Disclaimer
]